01 5Belmore Neidrauer LLP
02 4Blake Cassels & Graydon LLP
03 4Bristol-Myers Squibb Canada
04 16Gilead Sciences Canada Inc.
01 12250840
02 12261619
03 12298059
04 12317736
05 22416757
06 22470365
07 12485834
08 22566922
09 62678907
10 62720856
11 22845553
12 22847871
13 22872424
01 4ATAZANAVIR SULFATE | COBICISTAT
02 2COBICISTAT
03 4DARUNAVIR ETHANOLATE | COBICISTAT
04 5DARUNAVIR ETHANOLATE | COBICISTAT | EMTRICITABINE | TENOFOVIR ALAFENAMIDE HEMIFUMARATE
05 7ELVITEGRAVIR | COBICISTAT | EMTRICITABINE | TENOFOVIR ALAFENAMIDE HEMIFUMARATE
06 7Elvitegravir | Cobicistat | Emtricitabine | Tenofovir disoproxil fumarate
01 22TABLET
02 7Tablet
01 12017-04-14
02 12017-07-25
03 12018-07-23
04 12018-12-22
05 22019-06-23
06 22021-07-20
07 12023-05-16
08 22023-11-20
09 22025-05-19
10 22026-12-29
11 62028-02-22
12 62029-05-01
13 22032-08-15
Patent Expiration Date : 2017-04-14
Date Granted : 2006-07-04
ATAZANAVIR SULFATE, COBICISTAT
Brand Name : EVOTAZ
Patent Number : 2250840
Filing Date : 1997-04-14
Strength per Unit : 300 mg / 150 mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2017-04-14
Date Granted : 2006-07-04
Patent Expiration Date : 2018-12-22
Date Granted : 2004-11-02
ATAZANAVIR SULFATE, COBICISTAT
Brand Name : EVOTAZ
Patent Number : 2317736
Filing Date : 1998-12-22
Strength per Unit : 300 mg / 150 mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2018-12-22
Date Granted : 2004-11-02
Patent Expiration Date : 2028-02-22
Date Granted : 2014-06-17
ATAZANAVIR SULFATE, COBICISTAT
Brand Name : EVOTAZ
Patent Number : 2678907
Filing Date : 2008-02-22
Strength per Unit : 300 mg / 150 mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2028-02-22
Date Granted : 2014-06-17
Patent Expiration Date : 2029-05-01
Date Granted : 2016-02-02
ATAZANAVIR SULFATE, COBICISTAT
Brand Name : EVOTAZ
Patent Number : 2720856
Filing Date : 2009-05-01
Strength per Unit : 300 mg / 150 mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2029-05-01
Date Granted : 2016-02-02
Patent Expiration Date : 2026-12-29
Date Granted : 2016-07-26
Elvitegravir, Cobicistat, Emtricitabine, Tenofovir disoproxil fumarate
Brand Name : STRIBILD
Patent Number : 2847871
Filing Date : 2006-12-29
Strength per Unit : 150 mg / 150 mg / 200 mg / 300 mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2026-12-29
Date Granted : 2016-07-26
Patent Expiration Date : 2017-07-25
Date Granted : 2006-05-23
Elvitegravir, Cobicistat, Emtricitabine, Tenofovir disoproxil fumarate
Brand Name : STRIBILD
Patent Number : 2261619
Filing Date : 1997-07-25
Strength per Unit : 150 mg / 150 mg / 200 mg / 300 mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2017-07-25
Date Granted : 2006-05-23
Patent Expiration Date : 2025-05-19
Date Granted : 2011-01-11
Elvitegravir, Cobicistat, Emtricitabine, Tenofovir disoproxil fumarate
Brand Name : STRIBILD
Patent Number : 2566922
Filing Date : 2005-05-19
Strength per Unit : 150 mg / 150 mg / 200 mg / 300 mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2025-05-19
Date Granted : 2011-01-11
Patent Expiration Date : 2018-07-23
Date Granted : 2008-12-30
Elvitegravir, Cobicistat, Emtricitabine, Tenofovir disoproxil fumarate
Brand Name : STRIBILD
Patent Number : 2298059
Filing Date : 1998-07-23
Strength per Unit : 150 mg / 150 mg / 200 mg / 300 mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2018-07-23
Date Granted : 2008-12-30
Patent Expiration Date : 2023-11-20
Date Granted : 2011-05-17
Elvitegravir, Cobicistat, Emtricitabine, Tenofovir disoproxil fumarate
Brand Name : STRIBILD
Patent Number : 2470365
Filing Date : 2003-11-20
Strength per Unit : 150 mg / 150 mg / 200 mg / 300 mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2023-11-20
Date Granted : 2011-05-17
Patent Expiration Date : 2028-02-22
Date Granted : 2014-06-17
Elvitegravir, Cobicistat, Emtricitabine, Tenofovir disoproxil fumarate
Brand Name : STRIBILD
Patent Number : 2678907
Filing Date : 2008-02-22
Strength per Unit : 150 mg / 150 mg / 200 mg / 300 mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2028-02-22
Date Granted : 2014-06-17
